Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2015

Baird Cuts Price Target on Enanta Pharma (ENTA) Despite Bottom-Line Beat

February 9, 2016 7:28 AM EST

Baird remains Neutral on Enanta Pharmaceuticals (NASDAQ: ENTA), and cut the price target to $22.00 (from $36.00), following the company's 1Q. Non-GAAP EPS was reported at $1.36, beating consensus estimates of $1.13. The company ended the quarter with $236.6M in cash, which management expects will last for the... More

Enanta Pharma (ENTA) Tops Q1 EPS by 23c

February 8, 2016 4:05 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $1.36, $0.23 better than the analyst estimate of $1.13. Revenue for the quarter came in at $48.4 million versus the consensus estimate of $47.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More